Melanoma vaccines: prim and proper presentation

Comment

J M Timmerman et al. Nat Med. 1998 Mar.

. 1998 Mar;4(3):269-70.

doi: 10.1038/nm0398-269.

No abstract available

Comment on

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma.
Rosenberg SA, Yang JC, Schwartzentruber DJ, Hwu P, Marincola FM, Topalian SL, Restifo NP, Dudley ME, Schwarz SL, Spiess PJ, Wunderlich JR, Parkhurst MR, Kawakami Y, Seipp CA, Einhorn JH, White DE. Rosenberg SA, et al. Nat Med. 1998 Mar;4(3):321-7. doi: 10.1038/nm0398-321. Nat Med. 1998. PMID: 9500606 Free PMC article. Clinical Trial.
Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells.
Nestle FO, Alijagic S, Gilliet M, Sun Y, Grabbe S, Dummer R, Burg G, Schadendorf D. Nestle FO, et al. Nat Med. 1998 Mar;4(3):328-32. doi: 10.1038/nm0398-328. Nat Med. 1998. PMID: 9500607 Clinical Trial.